Roche CEO: Future of cancer treatment, AI in Medicine and Trial Challenges

Roche CEO: Future of cancer treatment, AI in ...

Up next

Saul Perlmutter: The Accelerating Universe, Doubt as a Superpower and the Science of Collaboration

Hosted on Acast. See acast.com/privacy for more information. 

HIGHLIGHTS: Kristalina Georgieva

We've curated a special 10-minute version of the podcast for those in a hurry. Here you can listen to the full episode: https://podcasts.apple.com/no/podcast/kristalina-georgieva-leading-the-imf-navigating/id1614211565?i=1000741623513&l=nbWhat does it take to keep the global econ ...  Show more

Recommended Episodes

Ray Dalio on AI, Job Loss & the Future of the Economy | #EP 148
Moonshots with Peter Diamandis

In this episode, Ray and Peter discuss the changing world order, China vs. the USA, and Ray’s thoughts on the future of the US. Recorded on Feb 3rd, 2025 Views are my own thoughts; not Financial, Medical, or Legal Advice. Ray Dalio is a renowned investor, hedge fund manager, an ...  Show more

Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing
All-In with Chamath, Jason, Sacks & Friedberg

(0:00) Introducing Eli Lilly CEO Dave Ricks

(1:43) How Eli Lilly discovered the GLP-1 impact on weight loss, counterfeit products from China

(7:08) GLP-1 pricing and capital allocation after a breakout pharma product

(12:56) Why Biotech VC has plummeted, " ...

  Show more

AI Biohacking Breakthroughs: Transform Your Health with Gary Brecka's Top Strategies | EP #149
Moonshots with Peter Diamandis

In this episode, Gary and Peter discuss the most important bio hacks people should know and cover a list of health tech gadgets they have at home and use daily to live longer.  Recorded on Jan 23rd, 2024 Views are my own thoughts; not Financial, Medical, or Legal Advice. Gary B ...  Show more

How AI Will Accelerate Breakthroughs in Biotechnology with Benchling CEO Sajith Wickramasekara
No Priors: Artificial Intelligence | Technology | Startups

Bringing new drugs to market is a costly, time-consuming endeavor. On top of that, most medicines fail at some point in the research and development phase. Sarah Guo is joined by Sajith Wickramasekara, co-founder and CEO of Benchling, a company that has not only become the centra ...  Show more